Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.

Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, Wenseleers T, Gimma A, Waites W, Wong KLM, van Zandvoort K, Silverman JD, CMMID COVID-19 Working Group, COVID-19 Genomics UK (COG-UK) Consortium, Diaz-Ordaz K, Keogh R, Eggo RM, Funk S, Jit M, Atkins KE, Edmunds WJ. · 2021

Read Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. by Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, Wenseleers T, Gimma A, Waites W, Wong KLM, van Zandvoort K, Silverman JD, CMMID COVID-19 Working Group, COVID-19 Genomics UK (COG-UK) Consortium, Diaz-Ordaz K, Keogh R, Eggo RM, Funk S, Jit M, Atkins KE, Edmunds WJ. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8128288.txt.

Description

Davies and co-authors estimate how fast the UK coronavirus variant spread and what it would do. The variant, flagged as VOC 202012/01, rose during England's November lockdown. It carried 17 mutations, eight of them in the spike protein. Several changes plausibly sharpened binding to human cells. The team attacked the growth data with several models. Statistical and dynamic approaches were run in parallel.

All routes converged on a faster-spreading virus. The variant proved 43 to 90% more transmissible than earlier lineages in their estimates. No clear sign emerged that it made people sicker. Faster spread alone means more cases and more admissions. By late March it made up roughly 95% of new infections in England. The authors warn of large resurgences when controls ease. Vaccine rollout speed becomes the deciding variable. A fitter variant rewrites the whole control problem.

Catalog record

CREATORDavies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, Wenseleers T, Gimma A, Waites W, Wong KLM, van Zandvoort K, Silverman JD, CMMID COVID-19 Working Group, COVID-19 Genomics UK (COG-UK) Consortium, Diaz-Ordaz K, Keogh R, Eggo RM, Funk S, Jit M, Atkins KE, Edmunds WJ.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8128288

Browse the full library · About the Tower of Babel